Related Experiment Video
Updated: Aug 6, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Fungal left ventricular assist device endocarditis
F Nurozler1, M Argenziano, M C Oz
1Department of Surgery, College of Physicians & Surgeons of Columbia University, New York, New York, USA.
Background:
Infection remains as the most serious complication and represents a significant threat to patients during long-term mechanical circulatory support. Fungal infection is a particularly worrisome complication and left ventricular assist device (LVAD) endocarditis does pose a serious threat.
Methods:
One hundred and sixty-five patients underwent TCI Heartmate LVAD implantation between July 1991 and December 1999 at our institution. Detailed medical records were kept prospectively for all patients, and a variety of infection-related endpoints were analyzed on patients with fungal LVAD endocarditis.
Results:
Thirty-seven patients (22%) developed fungal infections during LVAD support. Five (3%) of those met our criteria for the diagnosis of fungal LVAD endocarditis. Microbial portals of entry were identifiable in all cases. Infections were managed successfully in 4 patients (80%).
Conclusions:
The successful management of fungal LVAD endocarditis currently requires early recognition of potentially nonspecific signs and symptoms, and timely institution of antifungal therapy. In some cases with device-specific manifestations of LVAD endocarditis, device removal and replacement is necessary. In patients with clinical manifestations of sepsis and fungal driveline site or pocket infections without positive blood culture, urgent transplantation may be the appropriate management. In the setting of shortage in the donor supply, device removal and replacement is necessary.
Insights
Fungal infections, including left ventricular assist device (LVAD) endocarditis, are serious complications in patients with mechanical circulatory support. Early recognition and antifungal therapy are key to successful management, with device replacement sometimes necessary.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Devices
Background:
- Infection is a major threat for patients on long-term mechanical circulatory support.
- Fungal infections, particularly left ventricular assist device (LVAD) endocarditis, pose a significant risk.
Purpose of the Study:
- To analyze the incidence, management, and outcomes of fungal LVAD endocarditis.
Main Methods:
- Retrospective analysis of 165 patients who underwent TCI Heartmate LVAD implantation.
- Prospective data collection on infection-related endpoints.
- Focus on patients diagnosed with fungal LVAD endocarditis.
Main Results:
- 37 patients (22%) developed fungal infections; 5 (3%) had fungal LVAD endocarditis.
- Identifiable microbial portals of entry in all cases.
- Successful management in 4 out of 5 patients (80%).
Conclusions:
- Early recognition of nonspecific signs and prompt antifungal therapy are crucial for managing fungal LVAD endocarditis.
- Device removal/replacement may be necessary for device-specific manifestations or sepsis.
- Urgent transplantation or device replacement is indicated in specific clinical scenarios.
More Related Videos
06:59Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
05:18Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
Published on: January 16, 2026
Related Concept Videos
Mitral Stenosis I: Introduction
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Cryptococcal Meningitis